YouTube as a platform to better understand the treatment of lymphoma using ibrutinib: a cross-sectional study

BACKGROUND: Ibrutinib, one Food and Drug Administration-approved, orally available, small-molecule Bruton tyrosine kinase (BTK) inhibitor, is an effective targeted therapy for patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). YouTube is increasingly used for health pur...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lin, Qiu, Xiuliang, Zhao, Qiuling, Qiu, Hongqiang, Cheng, Yu, Liu, Wenbin, Xie, Ruixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469172/
https://www.ncbi.nlm.nih.gov/pubmed/36111010
http://dx.doi.org/10.21037/atm-22-3577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469172/
https://www.ncbi.nlm.nih.gov/pubmed/36111010
http://dx.doi.org/10.21037/atm-22-3577

Ejemplares similares